1
EXHIBIT 11
NOVAMETRIX MEDICAL SYSTEMS INC.
STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS
QUARTER ENDED SIX MONTHS ENDED
11-02-97 10-27-96 11-02-97 10-27-96
-------- -------- -------- --------
Net Income $ 626,788 $ 696,158 $1,150,646 $1,344,032
PRIMARY EARNINGS PER SHARE:
Weighted average number of shares of
Common Stock outstanding 7,914,648 6,955,902 7,581,194 6,809,614
Net effect of dilutive common stock
equivalents (1) 1,167,457 1,197,477 1,079,349 1,171,142
Total weighted average number of shares
of Common Stock and dilutive common
stock equivalents outstanding ---------- ---------- ---------- ----------
9,082,105 8,153,379 8,660,543 7,980,756
========== ========== ========== ==========
Per common share amounts: $ 0.07 $ 0.09 $ 0.13 $ 0.17
========== ========== ========== ==========
FULLY DILUTED EARNINGS PER SHARE:
Weighted average number of shares of
Common Stock outstanding 7,914,648 6,955,902 7,581,194 6,809,614
Net effect of dilutive common stock
equivalents (1) 1,389,588 1,403,505 1,589,884 1,518,532
Total weighted average number of
shares of Common Stock and dilutive
common stock equivalents ---------- ---------- ---------- ----------
9,304,236 8,359,407 9,171,078 8,328,146
Per common share amounts: $ 0.07 $ 0.08 $ 0.13 $ 0.16
========== ========== ========== ==========
(1) Common stock equivalents consist of the Company's Preferred Stock, stock
options, warrants and shares subscribed under the Company's Employee Stock
Purchase Plan. The computation of dilutive common stock equivalents is based on
the if-converted method for the Preferred Stock and on the treasury stock method
for the other common stock equivalents using the average market price for the
primary earnings per share computations and the higher of average or period-end
market price for the fully diluted earnings per share computations.
Page 17 of 34